Influence of corticosteroids and prematurity on bone density in preterm neonates

Influence of corticosteroids and prematurity on bone density in preterm neonates - Corticosteroids and bone density

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31000

Enrollment

100

Registered

2007-04-23

Start date

2007-04-30

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis rickets

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Infants born with a gestational age of 26-34 weeks.

Exclusion criteria

Exclusion criteria: Multiple congenital anomalies.

Design outcomes

Primary

Measure	Time frame
Primary outcome of the study is a significant diminished SOS in children who have used corticosteroids as to children who don't have used corticosteroids.	—

Secondary

Measure	Time frame
Secundary outcome of the study is a wider influence of dexamethasone on bone density as hydrocortisone.	—

Countries

Netherlands

Outcome results